HERON THERAPEUTICS, INC. /DE/ Interest Income (Expense), Nonoperating, Net
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Interest Income (Expense), Nonoperating, Net of -$552.00 thousand for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2017-11-06
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for the quarter ending 2017-09-30 was -$552.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for the quarter ending 2017-06-30 was -$744.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for the quarter ending 2016-09-30 was -$775.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for the quarter ending 2016-06-30 was -$160.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for fiscal 2013 was -$826.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for fiscal 2012 was -$599.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for fiscal 2011 was -$373.00K.
- HERON THERAPEUTICS, INC. /DE/ interest income (expense), nonoperating, net for fiscal 2010 was -$2.00K, a 106.90% decline from fiscal 2009.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$552.00K 10-Q · filed 2017-11-06 | -$1.30M derived: sum of 2 quarters · filed 2017-11-06 | -$2.33M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | -$744.00K 10-Q · filed 2017-08-09 | -$1.77M 10-Q · filed 2017-08-09 | ||
| 2016-09-30 | -$775.00K 10-Q · filed 2017-11-06 | -$935.00K derived: sum of 2 quarters · filed 2017-11-06 | -$1.07M 10-Q · filed 2017-11-06 | |
| 2016-06-30 | -$160.00K 10-Q · filed 2017-08-09 | -$293.00K 10-Q · filed 2017-08-09 | ||
| 2013-12-31 | -$212.00K 10-K · filed 2014-03-07 | -$421.00K derived: sum of 2 quarters · filed 2014-03-07 | -$625.00K derived: sum of 3 quarters · filed 2014-03-07 | -$826.00K 10-K · filed 2014-03-07 |
| 2013-09-30 | -$209.00K 10-K · filed 2014-03-07 | -$413.00K derived: sum of 2 quarters · filed 2014-03-07 | -$614.00K 10-Q · filed 2013-11-12 | -$811.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2013-06-30 | -$204.00K 10-K · filed 2014-03-07 | -$405.00K 10-Q · filed 2013-08-08 | -$602.00K derived: sum of 3 quarters · filed 2014-03-07 | -$797.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2013-03-31 | -$201.00K 10-K · filed 2014-03-07 | -$398.00K derived: sum of 2 quarters · filed 2014-03-07 | -$593.00K derived: sum of 3 quarters · filed 2014-03-07 | -$739.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-12-31 | -$197.00K 10-K · filed 2014-03-07 | -$392.00K derived: sum of 2 quarters · filed 2014-03-07 | -$538.00K derived: sum of 3 quarters · filed 2014-03-07 | -$599.00K 10-K · filed 2014-03-07 |
| 2012-09-30 | -$195.00K 10-K · filed 2014-03-07 | -$341.00K derived: sum of 2 quarters · filed 2014-03-07 | -$402.00K 10-Q · filed 2013-11-12 | -$449.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | -$146.00K 10-K · filed 2014-03-07 | -$207.00K 10-Q · filed 2013-08-08 | -$254.00K derived: sum of 3 quarters · filed 2014-03-07 | -$316.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | -$61.00K 10-K · filed 2014-03-07 | -$108.00K derived: sum of 2 quarters · filed 2014-03-07 | -$170.00K derived: sum of 3 quarters · filed 2014-03-07 | -$433.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$109.00K derived: sum of 2 quarters · filed 2014-03-07 | -$372.00K derived: sum of 3 quarters · filed 2014-03-07 | -$373.00K 10-K · filed 2014-03-07 |
| 2011-09-30 | -$62.00K 10-Q · filed 2012-11-05 | -$325.00K derived: sum of 2 quarters · filed 2012-11-05 | -$326.00K 10-Q · filed 2012-11-05 | -$326.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | -$263.00K 10-Q · filed 2012-08-09 | -$264.00K 10-Q · filed 2012-08-09 | -$264.00K derived: sum of 3 quarters · filed 2013-03-01 | -$265.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | -$1.00K 10-Q · filed 2012-05-10 | -$1.00K derived: sum of 2 quarters · filed 2013-03-01 | -$2.00K derived: sum of 3 quarters · filed 2013-03-01 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$1.00K derived: sum of 2 quarters · filed 2013-03-01 | -$2.00K 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$1.00K 10-Q · filed 2011-11-07 | -$2.00K 10-Q · filed 2011-11-07 | ||
| 2009-12-31 | $29.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |